Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases

Drug Deliv. 2023 Dec;30(1):2256495. doi: 10.1080/10717544.2023.2256495.ABSTRACTMagnetic Drug Targeting (MDT) is of particular interest to researchers because of its good loading efficiency, targeting accuracy, and versatile use in vivo. Cardiovascular Disease (CVD) is a global chronic disease with a high mortality rate, and the development of more precise and effective treatments is imminent. A growing number of studies have begun to explore the feasibility of MDT in CVD, but an up-to-date systematic summary is still lacking. This review discusses the current research status of MDT from guiding magnetic fields, magnetic nanocarriers, delivery channels, drug release control, and safety assessment. The current application status of MDT in CVD is also critically introduced. On this basis, new insights into the existing problems and future optimization directions of MDT are further highlighted.PMID:37702067 | PMC:PMC10501169 | DOI:10.1080/10717544.2023.2256495
Source: Drug Delivery - Category: Drugs & Pharmacology Authors: Source Type: research